Path:Home>About Us>Development History

February 20, 2019

Focuschem Biopharm Co., LTD., a wholly-owned subsidiary of Shandong Focuschem Biotech Co., LTD., was established

In April 2019

The annual output of 520 tons of medical-grade sodium hyaluronate project began construction

In July 2019

Shandong Focuschem Biotech Co., Ltd. was acquired by Lu Shang Health Industry Development Co., LTD

In November 2019

A production line with an annual output of 260 tons of sodium hyaluronate was built, and the achievements of establishment, construction and production in the same year were achieved

In February 2020

Selected as "Major Project of Shandong Province"

In March 2020

It has been listed as a key project of jining city's material production for emergency epidemic prevention and control


©2020 Shandong Focuschem Biotech Co., Ltd. 鲁ICP备19033309号-1